IL6 and Hepatic fibrosis: Additionally, FXR modulates inflammation by suppressing pro-inflammatory cytokines (TNF-α, IL-6) and inhibits hepatic stellate cell activation to exert anti-fibrotic effects, slowing liver fibrosis progression [33].